Drug Trial Radar · NCT06708299
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
Last checked: Nov 19, 2026Latest source record: Sep 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
110
Planned (sponsor's estimate)
Start
Apr 7, 2025
Primary completion
Sep 21, 2026
Study completion Oct 21, 2026
Sponsor
- Lead sponsor
- Cardiol Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 27, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Multi-center, randomized, double-blind, placebo-controlled, phase-3 Trial. Patients with a history of recurrent pericarditis who are being treated with an IL-1 blocker for at least 12 months, scheduled to be discontinued, will be approached for potential trial participation. Double-blind treatment will be initiated 10 - 16 days prior to the last scheduled dose of the IL-1 blocker and continued for 24 weeks. The objective is to assess whether patients remain free of pericarditis recurrence while receiving CardiolRx.
Conditions
- Recurrent Pericarditis
Interventions
CardiolRxDrug
The intervention will be administered orally (via syringe) with food twice daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- time to pericarditis recurrenceTime frame: 24 weeks
Locations
27 sites in 4 countries. Site status is shown where the registry gives one.
Mayo Clionic Arizona
Phoenix, Arizona · Recruiting
UCI Health
Irvine, California · Recruiting
Altman Clinical and Translational Research Institute
La Jolla, California · Recruiting
Cedars-Sinai Medical Center
Los Angeles, California · Recruiting
Pacific Heart Institute at Cedars-Sinai
Santa Monica, California · Recruiting
Mayo Clinic Florida
Jacksonville, Florida · Recruiting
Northwestern University
Chicago, Illinois · Recruiting
Johns Hopkins University
Baltimore, Maryland · Recruiting
MedStar Health Institute
Columbia, Maryland · Recruiting
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
Minneapolis Heart Institute
Minneapolis, Minnesota · Recruiting
Mayo Clinic
Rochester, Minnesota · Recruiting
NYU Langone Health
New York, New York · Recruiting
Columbia University - New York Presbyterian
New York, New York · Recruiting
Lenox Hill Hospital
New York, New York · Recruiting
Cleveland Clinic
Cleveland, Ohio · Recruiting
Houston Methodist Hospital
Houston, Texas · Recruiting
University of Utah Hospital
Salt Lake City, Utah · Recruiting
University of Vermont
Burlington, Vermont · Recruiting
University of Virginia
Charlottesville, Virginia · Recruiting
Virginia Commonwealth University
Richmond, Virginia · Recruiting
Jewish General Hospital
Montreal, Canada · Recruiting
Hippokration General Hospital
Athens, Greece · Recruiting
Fatebenefratelli Hospital Milano
Milan, Italy · Not yet recruiting
University of Padua
Padua, Italy · Not yet recruiting
University Hospital
Torino, Italy · Not yet recruiting
University Hospital Udine
Udine, Italy · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.